"Alembic Pharmaceuticals Ltd (Alembic) today announced it has received final approval from the US Food Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Bosentan tablets, 62.5 mg and 125 mg," the firm said in a BSE filing.Alembic Pharma gets final USFDA nod for hypertension drug
"Alembic Pharmaceuticals Ltd (Alembic) today announced it has received final approval from the US Food Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Bosentan tablets, 62.5 mg and 125 mg," the firm said in a BSE filing.
Subscribe to:
Post Comments (Atom)
-
"The (latest) investment will be used to grow the mobile esports format and establish presence in select overseas markets through its ...
-
The NCLT#39;s Ahmedabad bench has directed the RP to include GAIL in the list of creditors for both the companies.
-
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology f...
No comments:
Post a Comment